Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulse Actinomycin-D for Failed Low Risk Gestational Trophoblastic Neoplasia
NCT00003688Phase 2Completed
- Sponsor
- GOG Foundation
- Start
- Oct 1999
- Primary completion
- Sep 2006
- Modality
- DNA Intercalators/Alkylators
- Countries
- 2
01
Overview
Phase 2, open-label, single-arm trial of actinomycin D in gestational trophoblastic neoplasia (GTN), sponsored by GOG Foundation. Primary endpoints: Efficacy of dactinomycin and Toxicity of dactinomycin. Started Oct 1999; status: completed.
02
Drugs
actinomycin D
03
Conditions
gestational trophoblastic neoplasia (GTN)
Beyond the preview
Go deeper on NCT00003688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003688.